Increasing Access and Participation in Early Phase Cancer Trials
Official title: Increasing Access and Participation to Early Phase Clinical Trials
Funded at University of Kansas Medical Center · NIH-11414868 · Data updated 2026-11-12
This project aims to help more cancer patients access early-stage clinical trials and participate in cutting-edge therapies that could benefit them sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kansas Medical Center NIH-funded |
| Lab location | 1 site (Kansas City, United States) |
| Project start | August 7, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $159,574 |
| NIH project number | 5R50CA290098-03 |
| Project ID | NIH-11414868 on NIH RePORTER |
Who could benefit from this research
✓Could help
Cancer patients within the catchment area who are eligible for early phase experimental therapeutics and have biomarker-informed profiles.
✕Less likely to help
Patients without eligible biomarker targets or those not suitable for early phase trials may not benefit.
What this research studies
If you have cancer and want access to experimental therapies, this project works to reduce barriers to enroll in early phase trials. It uses a structured plan to identify unmet needs, streamline trial activation, and engage doctors across the catchment area so patients can learn about and join trials that fit their tumors. The work includes analyzing how patients are referred for trials, coordinating tumor genomic characterization to match biomarkers, and improving workflows to speed up trial starts. The goal is to make early phase experimental treatments more accessible and timely for patients, including Veterans, through the University of Kansas Cancer Center infrastructure. It builds on lessons from NCI-supported trials to create sustainable, patient-centered processes.
Why it matters
Potential benefit: Patients could gain faster access to promising new therapies and potentially improved outcomes through earlier trial participation.
How similar studies have gone: Prior efforts in optimizing ETCTN trial activation and patient access have shown improvements in enrollment and trial efficiency, though the area remains challenging.
Where this research is happening
-
University of Kansas Medical Center
Kansas City, United States Active
Researchers
- Principal investigator: Baranda, Joaquina C — University of Kansas Medical Center
- Study coordinator: Baranda, Joaquina C
Related research
Other NIH-funded projects on the same topics.
-
Motor-Cognitive Training for Older Adults at Risk of Dementia
A Phase II trial tests a combined motor and cognitive training program for older adults at risk of dementia to see if it helps daily function and slows dementia onset.
-
MOVE Peds: Moving Toward Better Outcomes for Pediatric FSHD
A study in kids with a rare muscle disease (FSHD) will test how well certain outcomes reflect change and help guide future clinical trials.
-
How DNA methylation changes in our cells affect gene activity
This project studies how chemical changes to DNA, and the way DNA is packaged, influence how genes turn on or off in vertebrate cells.
-
Dietary oxysterols and metabolic dysfunction in the gut-liver axis
Aims to understand how oxidized cholesterol byproducts in processed foods affect gut and liver health, especially in adults with type 2 diabetes or related conditions.
-
Intermittent fasting and blood sugar in adults with diabetes
A study will look at how two forms of intermittent fasting might improve blood sugar control in adults with type 2 diabetes.
-
Dysfunctional fat tissue and its link to fatty liver and diabetes
Researchers are studying how problems in fat tissue contribute to fatty liver disease and type 2 diabetes in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.